Multiple preoperative endoscopic interventions are associated with worse outcomes after laparoscopic Heller myotomy for achalasia

Journal of Gastrointestinal Surgery

Volumn 13, Issue 12, 2009, Pages 2095-2103

  Snyder, Christopher W ^a   Burton, Ryan C ^b   Brown, Lindsay E ^b   Kakade, Manasi S ^a   Finan, Kelly R ^c   Hawn, Mary T ^a,d  

^a Kentucky   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Achalasia; Botulinum toxin; Myotomy; Outcomes; Pneumatic dilation; Treatment failure

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; FEMALE; HUMAN; LAPAROSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; QUALITY OF LIFE; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; ESOPHAGEAL ACHALASIA; ESOPHAGOSCOPY; FEMALE; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; QUALITY OF LIFE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 71149104071     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-1049-6     Document Type: Article

References (32)

1. Costantini M, Zaninotto G, Guirroli E, Rizzetto C, Portale G, Ruol A, Nicoletti L, Ancona E. The laparoscopic Heller-Dor operation remains an effective treatment for esophageal achalasia at a minimum 6-year follow-up. Surg Endosc 2005; 19: 345-351.
2. Frantzides CT, Moore RE, Carlson MA, Madan AK, Zografakis JG, Keshavarzian A, Smith C. Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg 2004; 8: 18-23.
3. Patti MG, Molena D, Fisichella PM, Whang K, Yamada H, Perretta S, Way LW. Laparoscopic Heller myotomy and Dor fundoplication for achalasia: analysis of successes and failures. Arch Surg 2001; 136: 870-877.
4. Williams VA, Peters JH. Achalasia of the esophagus: a surgical disease. J Am Coll Surg 2009; 208: 151-162.
5. Zaninotto G, Costantini M, Rizzetto C, Zanatta L, Guirroli E, Portale G, Nicoletti L, Cavallin F, Battaglia G, Ruol A, Ancona E. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg 2008; 248: 986-993.
6. Kostic S, Kjellin A, Ruth M, Lonroth H, Johnsson E, Andersson M, Lundell L. Pneumatic dilatation or laparoscopic cardiomyotomy in the management of newly diagnosed idiopathic achalasia. Results of a randomized controlled trial. World J Surg 2007; 31: 470-478.
7. Zaninotto G, Annese V, Costantini M, Del Genio A, Costantino M, Epifani M, Gatto G, D'Onofrio V, Benini L, Contini S, Molena D, Battaglia G, Tardio B, Andriulli A, Ancona E. Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia. Ann Surg 2004; 239: 364-370.
8. Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53: 629-633.
9. Richter JE. Update on the management of achalasia: balloons, surgery and drugs. Expert Rev Gastroenterol Hepatol 2008; 2: 435-445.
10. Urbach DR, Hansen PD, Khajanchee YS, Swanstrom LL. A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection. J Gastrointest Surg 2001; 5: 192-205.
11. Rosemurgy A, Villadolid D, Thometz D, Kalipersad C, Rakita S, Albrink M, Johnson M, Boyce W. Laparoscopic Heller myotomy provides durable relief from achalasia and salvages failures after Botox or dilation. Ann Surg 2005; 241: 725-733. discussion 733-5.
12. Richardson WS, Willis GW, Smith JW. Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 2003; 17: 696-698.
13. Horgan S, Hudda K, Eubanks T, McAllister J, Pellegrini CA. Does botulinum toxin injection make esophagomyotomy a more difficult operation? Surg Endosc 1999; 13: 576-579.
14. Patti MG, Feo CV, Arcerito M, De Pinto M, Tamburini A, Diener U, Gantert W, Way LW. Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia. Dig Dis Sci 1999; 44: 2270-2276.
15. Peillon C, Fromont G, Auvray S, Siriser F. Achalasia: the case for primary laparoscopic treatment. Surg Laparosc Endosc Percutan Tech 2001; 11: 71-75.
16. Smith CD, Stival A, Howell DL, Swafford V. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than Heller myotomy alone. Ann Surg 2006; 243: 579-584. discussion 584-6.
17. Portale G, Costantini M, Rizzetto C, Guirroli E, Ceolin M, Salvador R, Ancona E, Zaninotto G. Long-term outcome of laparoscopic Heller-Dor surgery for esophageal achalasia: possible detrimental role of previous endoscopic treatment. J Gastrointest Surg 2005; 9: 1332-1339.
18. Bonavina L, Incarbone R, Reitano M, Antoniazzi L, Peracchia A. Does previous endoscopic treatment affect the outcome of laparoscopic Heller myotomy? Ann Chir 2000; 125: 45-49.
19. Deb S, Deschamps C, Allen MS, Nichols FC 3rd, Cassivi SD, Crownhart BS, Pairolero PC. Laparoscopic esophageal myotomy for achalasia: factors affecting functional results. Ann Thorac Surg 2005; 80: 1191-1194. discussion 1194-5.
20. Finan KR, Renton D, Vick CC, Hawn MT. Prevention of post-operative leak following laparoscopic Heller myotomy. J Gastrointest Surg 2008; 13: 200-205.
21. Cowgill SM, Villadolid DV, Al-Saadi S, Rosemurgy AS. Difficult myotomy is not determined by preoperative therapy and does not impact outcome. JSLS 2007; 11: 336-343.
22. Zaninotto G, Costantini M, Portale G, Battaglia G, Molena D, Carta A, Costantino M, Nicoletti L, Ancona E. Etiology, diagnosis, and treatment of failures after laparoscopic Heller myotomy for achalasia. Ann Surg 2002; 235: 186-192.
23. Pandolfino JE, Kwiatek MA, Nealis T, Bulsiewicz W, Post J, Kahrilas PJ. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008; 135: 1526-1533.
24. Katzka DA, Castell DO. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia. Am J Gastroenterol 1999; 94: 637-642.
25. Vittal H, Pasricha PF. Botulinum toxin for gastrointestinal disorders: therapy and mechanisms. Neurotox Res 2006; 9: 149-159.
26. Patti MG, Fisichella PM. Laparoscopic Heller myotomy and Dor fundoplication for esophageal achalasia. How I do it. J Gastrointest Surg 2008; 12: 764-766.
27. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci 2001; 46: 1540-1549.
28. Harnish JL, Darling GE, Diamant NE, Kortan PP, Tomlinson GA, Deitel W, Laporte A, Urbach DR. Patient-centered measures for achalasia. Surg Endosc 2007; 22: 1290-1293.
29. Huffmanm LC, Pandalai PK, Boulton BJ, James L, Starnes SL, Reed MF, Howington JA, Nussbaum MS. Robotic Heller myotomy: a safe operation with higher postoperative quality-of-life indices. Surgery 2007; 142: 613-618. discussion 618-20.
30. Lopushinsky SR, Urbach DR. Pneumatic dilatation and surgical myotomy for achalasia. JAMA 2006; 296: 2227-2233.
31. Csendes A, Smok G, Braghetto I, Gonzalez P, Henriquez A, Csendes P, Pizurno D. Histological studies of Auerbach's plexuses of the oesophagus, stomach, jejunum, and colon in patients with achalasia of the oesophagus: correlation with gastric acid secretion, presence of parietal cells and gastric emptying of solids. Gut 1992; 33: 150-154.
32. Gutierrez-Galiana E, Botoman VA, Bech H. Symptomatic gastroparesis in a patient with achalasia. J Clin Gastroenterol 1998; 27: 166-168.